맨위로

The World Leading Biopharmaceutical Company

Expert of Cell Therapeutics
for Brain Diseases
Core
Competency
01
Vision

Biomedical Company with world best technologies

About us →

02
Technologies

To create the most valuable therapy using human stem cells

MSC → NSC →

03
Therapeutics

To offer novel cell therapeutics to patients with brain diseases

Overview →

Newsroom
more →
Press Release
Medinno’s strategy with ‘pre-conditioned stem cell’ for neonatal neurological disorders
img

2022.04.01

Press Release
첨단재생의료 인증·특허 잇달아 획득… 올해부터 본격적으로 해외사업 나서
img

2022.03.28

Press Release
메디노, '미숙아 뇌실내 출혈' 치료제 개발단계 희귀의약품 지정
img

2022.01.03

Press Release
[YTN 사이언스] 신생아 뇌 질환 치료제 개발 기업 '메디노' CEO 인터뷰
img

2021.12.01

Press Release
메디노, 신생아 저산소성 허혈성 뇌병증 치료 조성물 기술 유럽 특허 등록
img

2021.11.09

Press Release
메디노, '인체세포등 관리업' 허가 획득
img

2021.11.04